Could GLP-1 receptor agonists like semaglutide treat addiction, alzheimer disease, and other conditions
Yes, with a caveat about timing
Alternative treatment options, dose adjustments, or additional support may be available to address your concerns whilst maintaining diabetes control
Administered as a subcutaneous weekly injection, it is a manifold single pharmacological agent that has the ability to significantly lower glucose levels, as well as improve insulin sensitivity, reduce weight and amend dyslipidemia favorably modifying the lipid profile
GLP-1 + B12 GLP-1 + B12 combines GLP-1 support with Vitamin B12 to support metabolic health, appetite awareness, energy production, and overall wellness as part of a structured lifestyle routine
Adequate protein and healthy fats supply clean fuel for the energy cycle